Featured
High dose flu vaccine may lower Alzheimer risk
Child Vaccines Nov 14, 2026
School Illness Nov 13, 2026
Growth Charts Nov 12, 2026
High dose flu vaccine may lower Alzheimer risk, according to researchers comparing outcomes for people...
Half of long COVID patients see significant improvement within three years, with over a quarter...
Breast bruises may not always be harmless, as they can sometimes be a sign of...
Read our latest Germ Control articles.
The Infectious Disease Society of America and European Society of Clinical Microbiology and Infectious Disease...
Cefiderocol exhibits improved in vitro activity against multidrug-resistant Gram-negative pathogens at IDWeek 2026, with MICs...
Living with polycythemia vera requires balance and paying attention to body cues to avoid overexertion.
High dose flu vaccine may lower Alzheimer risk, according to researchers comparing outcomes for people who received the larger-dose formulation.
High dose flu vaccine may lower Alzheimer risk, according to researchers comparing outcomes for people who received the larger-dose formulation.
LAC DPH reports a rise in extensively drug-resistant Shigella cases in 2024, with 68 cases reported, up from 45 in...
CDC raises four drug-resistant pathogens to highest threat level, highlighting urgent public health risks and healthcare system strain in 2026.
Man contracts rare infection after swimming in Amazon, experiencing daily fevers and chills.
Vir Biotechnology’s elebsiran and tobevibart duo hits key phase 3 trial milestone, with 44% of patients achieving undetectable HDV RNA...
The Infectious Disease Society of America and European Society of Clinical Microbiology and Infectious Disease released consensus statements on September...
Measles cases surge with 5,182 infections and three fatalities reported across multiple U.S. states, according to the CDC.
Half of long COVID patients see significant improvement within three years, with over a quarter experiencing complete remission of symptoms.
Labcorp's new hepatitis D testing reflex option aims to close the diagnostic gap, targeting U.S. hepatitis B patients where only...
New study reveals ceftobiprole’s nearly full effectiveness against MRSA in the first US surveillance results since FDA approval, with key...